Skip to main content
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2000 Sep;83(2):F79–F85. doi: 10.1136/fn.83.2.F79

Management of preterm labour

S Vause, T Johnston
PMCID: PMC1721160  PMID: 10952696

Full Text

The Full Text of this article is available as a PDF (167.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerlund M., Strömberg P., Hauksson A., Andersen L. F., Lyndrup J., Trojnar J., Melin P. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol. 1987 Nov;94(11):1040–1044. doi: 10.1111/j.1471-0528.1987.tb02287.x. [DOI] [PubMed] [Google Scholar]
  2. Alfirevic Z., Boer K., Borcklehurst P., Buimer M., Elbourne D., Kok J., Tansey S. Two trials of antenatal thyrotrophin-releasing hormone for fetal maturation: stopping before the due date. Antenatal TRH Trial and the Thyroneth Trial Groups. Br J Obstet Gynaecol. 1999 Sep;106(9):898–906. doi: 10.1111/j.1471-0528.1999.tb08427.x. [DOI] [PubMed] [Google Scholar]
  3. Andersen H. F., Nugent C. E., Wanty S. D., Hayashi R. H. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol. 1990 Sep;163(3):859–867. doi: 10.1016/0002-9378(90)91084-p. [DOI] [PubMed] [Google Scholar]
  4. Anthony G. S., Calder A. A., MacNaughton M. C. Cervical resistance in patients with previous spontaneous mid-trimester abortion. Br J Obstet Gynaecol. 1982 Dec;89(12):1046–1049. doi: 10.1111/j.1471-0528.1982.tb04662.x. [DOI] [PubMed] [Google Scholar]
  5. Barclay C. G., Brennand J. E., Kelly R. W., Calder A. A. Interleukin-8 production by the human cervix. Am J Obstet Gynecol. 1993 Sep;169(3):625–632. doi: 10.1016/0002-9378(93)90634-u. [DOI] [PubMed] [Google Scholar]
  6. Bejar R., Curbelo V., Davis C., Gluck L. Premature labor. II. Bacterial sources of phospholipase. Obstet Gynecol. 1981 Apr;57(4):479–482. [PubMed] [Google Scholar]
  7. Bennett P. R., Slater D., Sullivan M., Elder M. G., Moore G. E. Changes in amniotic arachidonic acid metabolism associated with increased cyclo-oxygenase gene expression. Br J Obstet Gynaecol. 1993 Nov;100(11):1037–1042. doi: 10.1111/j.1471-0528.1993.tb15143.x. [DOI] [PubMed] [Google Scholar]
  8. Besinger R. E., Niebyl J. R., Keyes W. G., Johnson T. R. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol. 1991 Apr;164(4):981–988. doi: 10.1016/0002-9378(91)90569-d. [DOI] [PubMed] [Google Scholar]
  9. Bocking A. D. Preterm labour: recent advances in understanding of pathophysiology, diagnosis and management. Curr Opin Obstet Gynecol. 1998 Apr;10(2):151–156. doi: 10.1097/00001703-199804000-00012. [DOI] [PubMed] [Google Scholar]
  10. Caritis S. N., Chiao J. P., Kridgen P. Comparison of pulsatile and continuous ritodrine administration: effects on uterine contractility and beta-adrenergic receptor cascade. Am J Obstet Gynecol. 1991 Apr;164(4):1005–1012. doi: 10.1016/0002-9378(91)90574-b. [DOI] [PubMed] [Google Scholar]
  11. Carlan S. J., O'Brien W. F., O'Leary T. D., Mastrogiannis D. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol. 1992 Feb;79(2):223–228. [PubMed] [Google Scholar]
  12. Cole R. M., Lamont R. F. Current perspectives on drug treatment for preterm labour. J Obstet Gynaecol. 1998 Jul;18(4):309–314. doi: 10.1080/01443619867001. [DOI] [PubMed] [Google Scholar]
  13. Corwin M. J., Mou S. M., Sunderji S. G., Gall S., How H., Patel V., Gray M. Multicenter randomized clinical trial of home uterine activity monitoring: pregnancy outcomes for all women randomized. Am J Obstet Gynecol. 1996 Nov;175(5):1281–1285. doi: 10.1016/s0002-9378(96)70041-8. [DOI] [PubMed] [Google Scholar]
  14. Creasy R. K., Gummer B. A., Liggins G. C. System for predicting spontaneous preterm birth. Obstet Gynecol. 1980 Jun;55(6):692–695. [PubMed] [Google Scholar]
  15. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997 Jul;42(1):1–8. doi: 10.1203/00006450-199707000-00001. [DOI] [PubMed] [Google Scholar]
  16. Duty S., Weston A. H. Potassium channel openers. Pharmacological effects and future uses. Drugs. 1990 Dec;40(6):785–791. doi: 10.2165/00003495-199040060-00002. [DOI] [PubMed] [Google Scholar]
  17. Egarter C. H., Husslein P. Biochemistry of myometrial contractility. Baillieres Clin Obstet Gynaecol. 1992 Dec;6(4):755–769. doi: 10.1016/s0950-3552(05)80187-7. [DOI] [PubMed] [Google Scholar]
  18. Garfield R. E., Sims S., Daniel E. E. Gap junctions: their presence and necessity in myometrium during parturition. Science. 1977 Dec 2;198(4320):958–960. doi: 10.1126/science.929182. [DOI] [PubMed] [Google Scholar]
  19. Hanssens M. C., Selby C., Symonds E. M. Sex steroid hormone concentrations in preterm labour and the outcome of treatment with ritodrine. Br J Obstet Gynaecol. 1985 Jul;92(7):698–702. doi: 10.1111/j.1471-0528.1985.tb01451.x. [DOI] [PubMed] [Google Scholar]
  20. Hay P. E., Lamont R. F., Taylor-Robinson D., Morgan D. J., Ison C., Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 1994 Jan 29;308(6924):295–298. doi: 10.1136/bmj.308.6924.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hemminki E., Starfield B. Prevention and treatment of premature labour by drugs: review of controlled clinical trials. Br J Obstet Gynaecol. 1978 Jun;85(6):411–417. doi: 10.1111/j.1471-0528.1978.tb14906.x. [DOI] [PubMed] [Google Scholar]
  22. Hibbard B. The aetiology of preterm labour. Br Med J (Clin Res Ed) 1987 Mar 7;294(6572):594–595. doi: 10.1136/bmj.294.6572.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Higby K., Xenakis E. M., Pauerstein C. J. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol. 1993 Apr;168(4):1247–1259. doi: 10.1016/0002-9378(93)90376-t. [DOI] [PubMed] [Google Scholar]
  24. Hueston W. J., Knox M. A., Eilers G., Pauwels J., Lonsdorf D. The effectiveness of preterm-birth prevention educational programs for high-risk women: a meta-analysis. Obstet Gynecol. 1995 Oct;86(4 Pt 2):705–712. doi: 10.1016/0029-7844(95)00202-3. [DOI] [PubMed] [Google Scholar]
  25. King J. F., Grant A., Keirse M. J., Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 1988 Mar;95(3):211–222. doi: 10.1111/j.1471-0528.1988.tb06860.x. [DOI] [PubMed] [Google Scholar]
  26. Kurki T., Sivonen A., Renkonen O. V., Savia E., Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol. 1992 Aug;80(2):173–177. [PubMed] [Google Scholar]
  27. Lamont R. F., Taylor-Robinson D., Newman M., Wigglesworth J., Elder M. G. Spontaneous early preterm labour associated with abnormal genital bacterial colonization. Br J Obstet Gynaecol. 1986 Aug;93(8):804–810. doi: 10.1111/j.1471-0528.1986.tb07987.x. [DOI] [PubMed] [Google Scholar]
  28. Lamont R. F., Taylor-Robinson D., Wigglesworth J. S., Furr P. M., Evans R. T., Elder M. G. The role of mycoplasmas, ureaplasmas and chlamydiae in the genital tract of women presenting in spontaneous early preterm labour. J Med Microbiol. 1987 Nov;24(3):253–257. doi: 10.1099/00222615-24-3-253. [DOI] [PubMed] [Google Scholar]
  29. Leeson S., Maresh M. Fibronectin: a predictor of preterm delivery? Br J Obstet Gynaecol. 1993 Apr;100(4):304–306. doi: 10.1111/j.1471-0528.1993.tb12968.x. [DOI] [PubMed] [Google Scholar]
  30. Leveno K. J., Cox K., Roark M. L. Cervical dilatation and prematurity revisited. Obstet Gynecol. 1986 Sep;68(3):434–435. doi: 10.1097/00006250-198609000-00031. [DOI] [PubMed] [Google Scholar]
  31. Lockwood C. J., Senyei A. E., Dische M. R., Casal D., Shah K. D., Thung S. N., Jones L., Deligdisch L., Garite T. J. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991 Sep 5;325(10):669–674. doi: 10.1056/NEJM199109053251001. [DOI] [PubMed] [Google Scholar]
  32. Magocsi M., Penniston J. T. Oxytocin pretreatment of pregnant rat uterus inhibits Ca2+ uptake in plasma membrane and sarcoplasmic reticulum. Biochim Biophys Acta. 1991 Mar 18;1063(1):7–14. doi: 10.1016/0005-2736(91)90346-a. [DOI] [PubMed] [Google Scholar]
  33. McGregor J. A., French J. I., Lawellin D., Todd J. K. Preterm birth and infection: pathogenic possibilities. Am J Reprod Immunol Microbiol. 1988 Mar;16(3):123–132. doi: 10.1111/j.1600-0897.1988.tb00181.x. [DOI] [PubMed] [Google Scholar]
  34. Meis P. J., Ernest J. M., Moore M. L. Causes of low birth weight births in public and private patients. Am J Obstet Gynecol. 1987 May;156(5):1165–1168. doi: 10.1016/0002-9378(87)90133-5. [DOI] [PubMed] [Google Scholar]
  35. Minkoff H., Grunebaum A. N., Schwarz R. H., Feldman J., Cummings M., Crombleholme W., Clark L., Pringle G., McCormack W. M. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 1984 Dec 15;150(8):965–972. doi: 10.1016/0002-9378(84)90392-2. [DOI] [PubMed] [Google Scholar]
  36. Morales W. J., Smith S. G., Angel J. L., O'Brien W. F., Knuppel R. A. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol. 1989 Oct;74(4):567–572. [PubMed] [Google Scholar]
  37. Neilson J. P., Verkuyl D. A., Crowther C. A., Bannerman C. Preterm labor in twin pregnancies: prediction by cervical assessment. Obstet Gynecol. 1988 Nov;72(5):719–723. [PubMed] [Google Scholar]
  38. Newman R. B., Godsey R. K., Ellings J. M., Campbell B. A., Eller D. P., Miller M. C., 3rd Quantification of cervical change: relationship to preterm delivery in the multifetal gestation. Am J Obstet Gynecol. 1991 Aug;165(2):264–271. doi: 10.1016/0002-9378(91)90077-5. [DOI] [PubMed] [Google Scholar]
  39. Norton M. E., Merrill J., Cooper B. A., Kuller J. A., Clyman R. I. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993 Nov 25;329(22):1602–1607. doi: 10.1056/NEJM199311253292202. [DOI] [PubMed] [Google Scholar]
  40. Owen J., Goldenberg R. L., Davis R. O., Kirk K. A., Copper R. L. Evaluation of a risk scoring system as a predictor of preterm birth in an indigent population. Am J Obstet Gynecol. 1990 Sep;163(3):873–879. doi: 10.1016/0002-9378(90)91086-r. [DOI] [PubMed] [Google Scholar]
  41. Papatsonis D. N., Van Geijn H. P., Adèr H. J., Lange F. M., Bleker O. P., Dekker G. A. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 1997 Aug;90(2):230–234. doi: 10.1016/S0029-7844(97)00182-8. [DOI] [PubMed] [Google Scholar]
  42. Rajabi M., Dean D. D., Woessner J. F., Jr High levels of serum collagenase in premature labor--a potential biochemical marker. Obstet Gynecol. 1987 Feb;69(2):179–186. [PubMed] [Google Scholar]
  43. Schrey M. P., Read A. M., Steer P. J. Oxytocin and vasopressin stimulate inositol phosphate production in human gestational myometrium and decidua cells. Biosci Rep. 1986 Jul;6(7):613–619. doi: 10.1007/BF01114755. [DOI] [PubMed] [Google Scholar]
  44. Slater D. M., Berger L. C., Newton R., Moore G. E., Bennett P. R. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):77–82. doi: 10.1016/0002-9378(95)90087-x. [DOI] [PubMed] [Google Scholar]
  45. Stubbs T. M., Van Dorsten J. P., Miller M. C., 3rd The preterm cervix and preterm labor: relative risks, predictive values, and change over time. Am J Obstet Gynecol. 1986 Oct;155(4):829–834. doi: 10.1016/s0002-9378(86)80031-x. [DOI] [PubMed] [Google Scholar]
  46. Tasaka K., Masumoto N., Miyake A., Tanizawa O. Direct measurement of intracellular free calcium in cultured human puerperal myometrial cells stimulated by oxytocin: effects of extracellular calcium and calcium channel blockers. Obstet Gynecol. 1991 Jan;77(1):101–106. [PubMed] [Google Scholar]
  47. Thomson A. J., Lunan C. B., Cameron A. D., Cameron I. T., Greer I. A., Norman J. E. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynaecol. 1997 Sep;104(9):1054–1057. doi: 10.1111/j.1471-0528.1997.tb12066.x. [DOI] [PubMed] [Google Scholar]
  48. Thorp J. A., Ferrette-Smith D., Gaston L. A., Johnson J., Yeast J. D., Meyer B. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation. Obstet Gynecol. 1995 Jul;86(1):1–8. doi: 10.1016/0029-7844(95)00091-5. [DOI] [PubMed] [Google Scholar]
  49. Triggle D. J., Janis R. A. Calcium channel ligands. Annu Rev Pharmacol Toxicol. 1987;27:347–369. doi: 10.1146/annurev.pa.27.040187.002023. [DOI] [PubMed] [Google Scholar]
  50. Vermillion S. T., Scardo J. A., Lashus A. G., Wiles H. B. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol. 1997 Aug;177(2):256–261. doi: 10.1016/s0002-9378(97)70184-4. [DOI] [PubMed] [Google Scholar]
  51. Weston A. H., Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol. 1992 Jan 9;43(1):47–54. doi: 10.1016/0006-2952(92)90659-7. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES